| Filed On | Filing |
|---|---|
| 16 Feb 2021 | AMENDMENT NO. 3 TO SCHEDULE 13G |
| 12 Feb 2021 | SC 13G |
| 05 Mar 2020 | SC TO-I/A |
| 18 Feb 2020 | SC TO-I/A |
| 14 Feb 2020 | AMENDMENT NO. 1 TO THE SCHEDULE 13G |
| 14 Feb 2020 | AMENDMENT NO. 2 TO SCHEDULE 13G |
| 13 Feb 2020 | DECEMBER 31, 2019 |
| 07 Feb 2020 | AMENDMENT NO. 1 |
| 05 Feb 2020 | SC TO-I |
| 14 Jan 2020 | 15-15D |
| 13 Jan 2020 | 8-K: Regulation FD Disclosure |
| 07 Jan 2020 | SC 13G |
| 02 Jan 2020 |
Form 4: Freiman Daniel E, Chief Financial Officer
Sold 14,777 shares ($32.2K) |
| 30 Dec 2019 | FORM 25 |
| 26 Dec 2019 |
Form 4: Mulieri Timothy M, VP, Corporate Controller
Sold 34,376 shares ($74.3K) |
| 26 Dec 2019 | SC 13D/A |
| 23 Dec 2019 |
Form 4: Samberg Joseph D, Former 10% Owner
Sold 5,000,000 shares ($10.8M) · Acquired 1,000,000 shares (Open Market Sale) ($2.15M) |
| 23 Dec 2019 | SCHEDULE 13G AMENDMENT NO. 3 |
| 20 Dec 2019 | EFFECT |
| 19 Dec 2019 |
Form 4: Rogers Christopher Thomas, Director
Received 157,997 shares by exercise or conversion |
Loading...
